Advanced Search Results For "AND COVID-19 Subject OR COVID-19 pandemic Subject OR SARS-CoV-2 Subject OR SARS-CoV-2 Delta variant Subject OR SARS-CoV-2 Omicron variant Subject "
Your filters
Tozinameran: Transverse myelitis: case report.
Publication Type: Periodical
Source(s): Reactions Weekly; Sep2022, Vol. 1922 Issue 1, p557-557, 1p
Rituximab: COVID-19 infection: case report.
Publication Type: Periodical
Source(s): Reactions Weekly; Oct2022, Vol. 1928 Issue 1, p324-324, 1p
Abstract: Copyright of Reactions Weekly is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or em...
Mycophenolate-mofetil/prednisone/tacrolimus: COVID-19 infection: case report.
Publication Type: Periodical
Source(s): Reactions Weekly; 4/30/2022, Vol. 1904 Issue 1, p368-368, 1p
Tozinameran: Vaccine failure: 20 case reports.
Publication Type: Periodical
Source(s): Reactions Weekly. Apr2023, Vol. 1954 Issue 1, p417-417. 1p.
AZD-1222/tozinameran: Lack of efficacy: 2 case reports.
Publication Type: Periodical
Source(s): Reactions Weekly. Apr2023, Vol. 1953 Issue 1, p96-96. 1p.
Cilgavimab/tixagevimab unlikely to be active against some COVID-19 Omicron subvariants.
Publication Type: Periodical
Source(s): Reactions Weekly. 1/28/2023, Vol. 1941 Issue 1, p1-1. 1p.
Abstract: Health Canada is advising that EVUSHELD (cilgavimab/tixagevimab for injection) is unlikely to be active against some Omicron subvariants when used for the prevention or treatment of COVID-19 infection. The EVUSHELD Canadian Product Monograph (CPM) has ...
Sars-cov-2-vaccine inactivated sinovac biotech: Vaccine failure: case report.
Publication Type: Periodical
Source(s): Reactions Weekly. 1/21/2023, Vol. 1940 Issue 1, p379-379. 1p.
Covid-19-vaccine: Lack of efficacy: case report.
Publication Type: Periodical
Source(s): Reactions Weekly. 1/7/2023, Vol. 1938 Issue 1, p456-456. 1p.
Tozinameran: Vaccine failure: case report.
Publication Type: Periodical
Source(s): Reactions Weekly. Oct2022, Vol. 1929 Issue 1, p623-623. 1p.
Abstract: Epinephrine was restarted, her urticaria completely resolved and blood pressure improved. She was infected with COVID-19 despite administration of tozinameran vaacine, indicating vaccine failure. B Author Information b An event is serious (based on the...
Tozinameran: Lack of efficacy: case report.
Publication Type: Periodical
Source(s): Reactions Weekly. 12/17/2022, Vol. 1937 Issue 1, p439-439. 1p.
Abstract: Thereafter, he received 2 doses of tozinameran [BNT162b2] COVID-19 vaccine for immunisation against COVID-19. B Author Information b An event is serious (based on the ICH definition) when the patient outcome is: * death * life-threatening * hospi...